SEC Form 3 · accession 0001615774-18-002128
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Blake
Officer — Chief Financial Officer
Period of report
Mar 26, 2018
Accepted (ET)
Mar 27, 2018 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.97 | holding | — | — | — | Mar 26, 2019 | Mar 26, 2028 | Common Stock | 500,000 | — | D |
Explanation of responses
- F1500,000 unvested options granted pursuant to the Company's 2011 Equity Incentive Plan, and shares underlying unvested options, of which 125,000 options vest on March 26, 2019, with the remaining options vesting quarterly over three years thereafter, subject to continuous employment. These options have an exercise price of $1.97 per share and expire on March 26, 2028.